CONMED Corporation (CNMD)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 60.22 |
Market Cap | 1.89B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 4.25 |
PE Ratio (ttm) | 14.42 |
Forward PE | n/a |
Analyst | Hold |
Ask | 61.86 |
Volume | 276,711 |
Avg. Volume (20D) | 440,944 |
Open | 62.77 |
Previous Close | 63.02 |
Day's Range | 60.74 - 62.94 |
52-Week Range | 60.73 - 86.96 |
Beta | undefined |
About CNMD
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as suppor...
Analyst Forecast
According to 5 analyst ratings, the average rating for CNMD stock is "Hold." The 12-month stock price forecast is $75, which is an increase of 22.39% from the latest price.
Next Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription